FDA Pulls Warning Labels From Hormone Therapies

The US Food and Drug Administration announced that hormone replacement therapies no longer need to carry strict warnings about some potential side effects, and is asking drugmakers to remove the strict black box warnings to encourage more women to take the therapies. Icahn School of Medicine at Mount Sinai Associate Professor of Neurology Dr. Fanny Elahi believes this 'never warranted' warning being lifted is a positive development. "We need to make up for the lost time," Dr. Elahi said, "and advance the science to the point where we are more precise with the science." She joined Carol Massar and Tim Stenovec on 'Bloomberg Businessweek Daily' to discuss. (Source: Bloomberg)